Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Stem Cell Research

  Free Subscription

Articles published in Leuk Res

Retrieve available abstracts of 54 articles:
HTML format

Single Articles

    June 2021
  1. MOHAN M, Hari P, Szabo A, Dhakal B, et al
    Long term follow up of newly diagnosed multiple myeloma patients treated with pembrolizumab consolidation post-autologous stem cell transplantation.
    Leuk Res. 2021;109:106648.

  2. XUE E, Lorentino F, Pavesi F, Assanelli A, et al
    Ruxolitinib for chronic steroid-refractory graft versus host disease: a single center experience.
    Leuk Res. 2021;109:106642.
    PubMed     Abstract available

    May 2021
  3. YASUDA S, Najima Y, Konishi T, Yamada Y, et al
    Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
    Leuk Res. 2021;108:106627.
    PubMed     Abstract available

  4. FIEGLE E, Crysandt M, Bouillon AS, Silling G, et al
    Successful allogeneic stem cell transplantation of a patient with Werner syndrome and acute myeloid leukemia.
    Leuk Res. 2021 May 5:106609. doi: 10.1016/j.leukres.2021.106609.

    April 2021
  5. SPEROTTO A, Gottardi M, Candoni A, Toffoletti E, et al
    WT1 - Gene expression driven pre-emptive treatment with decitabine for molecular relapse of acute myeloid leukemia after allogeneic stem cell transplant.
    Leuk Res. 2021;108:106587.

  6. KATO H, Taji H, Kodaira T, Kinoshita T, et al
    Long-term engraftment stability of umbilical cord blood cells preserved in -135 degrees C mechanical freezers.
    Leuk Res. 2021;107:106590.

  7. MARTINEZ-ROCA A, Rodriguez-Lobato LG, Ballestar N, Gallego C, et al
    Personalized at-home autologous hematopoietic stem cell transplantation during the SARS-CoV-2 outbreak.
    Leuk Res. 2021;106:106589.

  8. LI S, Gu J, Nan W, Zhang N, et al
    Procalcitonin and C-reactive protein predict infection in hematopoietic stem cell transplantation patients.
    Leuk Res. 2021;105:106574.
    PubMed     Abstract available

    November 2020
  9. YANAGISAWA B, Perkins B, Karantanos T, Levis M, et al
    Expression of putative leukemia stem cell targets in genetically-defined acute myeloid leukemia subtypes.
    Leuk Res. 2020;99:106477.
    PubMed     Abstract available

  10. KUNIMOTO H, Nakajima H
    Clonal hematopoiesis: Molecular basis and clinical relevance.
    Leuk Res. 2020;98:106457.
    PubMed     Abstract available

    September 2020
  11. LIU T, Ahmed T, Krysiak K, Shirai CL, et al
    Haploinsufficiency of multiple del(5q) genes induce B cell abnormalities in mice.
    Leuk Res. 2020;96:106428.

    August 2020
  12. CICCARELLI BT, Hu T, Wang Q, Kim JJ, et al
    Examination of clinically-derived p210 BCR/ABL1 RhoGEF mutations in a murine bone marrow transplantation model of CML.
    Leuk Res. 2020;97:106440.
    PubMed     Abstract available

  13. DIRAL E, Parma M, Renso R, Pezzatti S, et al
    A fatal case of TEMPI syndrome, refractory to proteasome inhibitors and autologous stem cell transplantation.
    Leuk Res. 2020;97:106441.

    July 2020
  14. D'ANGELO CR, Hall A, Woo KM, Kim K, et al
    Decitabine induction with myeloablative conditioning and allogeneic hematopoietic stem cell transplantation in high-risk patients with myeloid malignancies is associated with a high rate of infectious complications.
    Leuk Res. 2020;96:106419.
    PubMed     Abstract available

    June 2020
  15. BRITT A, Mohyuddin GR, McClune B, Singh A, et al
    Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
    Leuk Res. 2020;95:106402.
    PubMed     Abstract available

    May 2020
  16. SIMONSEN AT, Bill M, Rosenberg CA, Hansen MH, et al
    Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression.
    Leuk Res. 2020;92:106350.

    March 2020
  17. YANG W, Xie J, Hou R, Chen X, et al
    Disulfiram/cytarabine eradicates a subset of acute myeloid leukemia stem cells with high aldehyde dehydrogenase expression.
    Leuk Res. 2020;92:106351.
    PubMed     Abstract available

    February 2020
  18. BAI L, Cheng YF, Lu AD, Suo P, et al
    Prognosis of haploidentical hematopoietic stem cell transplantation in non-infant children with t(v;11q23)/MLL-rearranged B-cell acute lymphoblastic leukemia.
    Leuk Res. 2020;91:106333.
    PubMed     Abstract available

    January 2020
  19. SEIPEL K, Messerli C, Wiedemann G, Bacher U, et al
    MN1, FOXP1 and hsa-miR-181a-5p as prognostic markers in acute myeloid leukemia patients treated with intensive induction chemotherapy and autologous stem cell transplantation.
    Leuk Res. 2020;89:106296.
    PubMed     Abstract available

    November 2019
  20. MASSE A, Roulin L, Pasanisi J, Penneroux J, et al
    BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias.
    Leuk Res. 2019;87:106269.
    PubMed     Abstract available

  21. GENG C, Liu X, Chen M, Yang C, et al
    Comparison of frontline treatment with intensive immunosuppression therapy and HLA-haploidentical hematopoietic stem cell transplantation for young patients with severe aplastic anemia - A meta analysis.
    Leuk Res. 2019;88:106266.
    PubMed     Abstract available

    October 2019
  22. MIYAMURA T, Kudo K, Tabuchi K, Ishida H, et al
    Hematopoietic stem cell transplantation for pediatric acute myeloid leukemia patients with KMT2A rearrangement; A nationwide retrospective analysis in Japan.
    Leuk Res. 2019;87:106263.
    PubMed     Abstract available

    September 2019
  23. NAKAMURA R, Gendzekhadze K, Palmer J, Tsai NC, et al
    Influence of donor KIR genotypes on reduced relapse risk in acute myelogenous leukemia after hematopoietic stem cell transplantation in patients with CMV reactivation.
    Leuk Res. 2019;87:106230.
    PubMed     Abstract available

    August 2019
  24. ANDRITSOS LA, Huang Y, Abraham I, Huff K, et al
    Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization.
    Leuk Res. 2019;85:106215.
    PubMed     Abstract available

    July 2019
  25. FALCONI G, Fabiani E, Criscuolo M, Fianchi L, et al
    Transcription factors implicated in late megakaryopoiesis as markers of outcome after azacitidine and allogeneic stem cell transplantation in myelodysplastic syndrome.
    Leuk Res. 2019;84:106191.
    PubMed     Abstract available

  26. HUANG SJ, Chan J, Bruyere H, Allan LL, et al
    Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada.
    Leuk Res. 2019;84:106193.
    PubMed     Abstract available

    June 2019
  27. KINSELLA FAM, Inman CF, Gudger A, Chan YT, et al
    Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease.
    Leuk Res. 2019;83:106173.
    PubMed     Abstract available

  28. MODI D, Surapaneni M, Kim S, Ayash L, et al
    Allogeneic stem cell transplant provides durable response in peripheral T-cell lymphoma.
    Leuk Res. 2019;83:106171.

  29. FANG J, Zhang R, Wang H, Hong M, et al
    Corrigendum to 'Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.' [L
    Leuk Res. 2019;81:107.

    May 2019
  30. JANN JC, Nolte F, Mossner M, Flach J, et al
    Comparative analysis of clonal hematopoiesis of multipotent stem cells in healthy elderly in blood and bone marrow.
    Leuk Res. 2019;82:15-18.

    April 2019
  31. MOSHAVER B, Wouters RF, Kelder A, Ossenkoppele GJ, et al
    Relationship between CD34/CD38 and side population (SP) defined leukemia stem cell compartments in acute myeloid leukemia.
    Leuk Res. 2019;81:27-34.
    PubMed     Abstract available

  32. SHIN DY, Park JK, Li CC, Park HS, et al
    Replicative senescence of hematopoietic cells in patients with idiopathic cytopenia of undetermined significance.
    Leuk Res. 2019;79:22-26.
    PubMed     Abstract available

    January 2019
  33. DANN EJ
    Should patient age be an obstacle for high-dose therapy and stem cell rescue?
    Leuk Res. 2019;78:34-35.

  34. LEMIEUX C, Ahmad I, Bambace NM, Bernard L, et al
    Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.
    Leuk Res. 2019 Jan 6. pii: S0145-2126(19)30002.
    PubMed     Abstract available

    November 2018
  35. ITONAGA H, Ota S, Ikeda T, Taji H, et al
    Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.
    Leuk Res. 2018;75:50-57.
    PubMed     Abstract available

    September 2018
  36. NAKAMURA M, Wu L, Griffin JD, Kojika S, et al
    Notch1 activation enhances proliferation via activation of cdc2 and delays differentiation of myeloid progenitors.
    Leuk Res. 2018;72:34-44.
    PubMed     Abstract available

    August 2018
  37. LI D, Lin TL, Lipe B, Hopkins RA, et al
    A novel extracellular matrix-based leukemia model supports leukemia cells with stem cell-like characteristics.
    Leuk Res. 2018;72:105-112.
    PubMed     Abstract available

  38. LEI H, Yang L, Zhou L, Tong Y, et al
    Targeting acute myeloid leukemia CD34(+) stem/progenitor cells with small molecule inhibitor MK-8776.
    Leuk Res. 2018;72:71-73.

  39. GURNARI C, Latagliata R, Buccisano F, Piciocchi A, et al
    Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes.
    Leuk Res. 2018;71:89-91.

    July 2018
  40. RIVERA-FRANCO MM, Leon-Rodriguez E, Lastra-German IK, Mendoza-Farias AA, et al
    Association of recipient and donor hypercholesterolemia prior allogeneic stem cell transplantation and graft-versus-host disease.
    Leuk Res. 2018;72:74-78.
    PubMed     Abstract available

  41. OGATA K, Sei K, Saft L, Kawahara N, et al
    Revising flow cytometric mini-panel for diagnosing low-grade myelodysplastic syndromes: Introducing a parameter quantifying CD33 expression on CD34+ cells.
    Leuk Res. 2018;71:75-81.
    PubMed     Abstract available

    June 2018
  42. LIU C, Wei H, Yao X, Liu B, et al
    Retraction notice to "Arsenic Trioxide Inhibits Proliferation and Induced apoptosis of Leukemia Stem Cells with Drug Resistance " [LR 69 (2018) 66-71].
    Leuk Res. 2018;69:103.

    May 2018
  43. IOVINO L, Mazziotta F, Carulli G, Guerrini F, et al
    High-dose zinc oral supplementation after stem cell transplantation causes an increase of TRECs and CD4+ naive lymphocytes and prevents TTV reactivation.
    Leuk Res. 2018;70:20-24.
    PubMed     Abstract available

    April 2018
  44. TANG L, Wang N, Xing C, Zhuang Q, et al
    Effect of absolute monocyte count post-transplant on the outcome of patients with acute myeloid leukemia undergoing myeloablative allogeneic hematopoietic stem cell transplant with busulfan and cyclophosphamide conditioning.
    Leuk Res. 2018;69:60-65.
    PubMed     Abstract available

  45. PARK H, Lee YJ, Shin SJ, Lee J, et al
    Which donor is better when a matched donor is not available domestically? Comparison of outcomes of allogeneic stem cell transplantation with haploidentical and international donors in a homogenous ethnic population.
    Leuk Res. 2018;69:31-38.
    PubMed     Abstract available

  46. LIU P, Jiang H, Che M, Fu R, et al
    Abnormal CD25 expression on hematopoietic cells in myelodysplastic syndromes.
    Leuk Res. 2018;67:12-16.
    PubMed     Abstract available

    March 2018
  47. LIU C, Wei H, Yao X, Liu B, et al
    Arsenic trioxide inhibits proliferation and induced apoptosis of leukemia stem cells with drug resistance.
    Leuk Res. 2018;69:66-71.
    PubMed     Abstract available

    January 2018
  48. CUI P, Zhang Y, Cui M, Li Z, et al
    Leukemia cells impair normal hematopoiesis and induce functionally loss of hematopoietic stem cells through immune cells and inflammation.
    Leuk Res. 2018;65:49-54.
    PubMed     Abstract available

    November 2017
  49. LEON-RODRIGUEZ E, Rivera-Franco MM, Gomez-Martin D, Romo-Tena J, et al
    Differential T cell subsets and cytokine profile between steady-state and G-CSF-primed bone marrow and its association with graft-versus-host disease.
    Leuk Res. 2017;63:47-52.
    PubMed     Abstract available

    October 2017
  50. OZDOGAN H, Gur Dedeoglu B, Oztemur Islakoglu Y, Aydos A, et al
    DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Leuk Res. 2017;63:62-71.
    PubMed     Abstract available

  51. CANDONI A, De Marchi F, Zannier ME, Lazzarotto D, et al
    High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission.
    Leuk Res. 2017;63:22-27.
    PubMed     Abstract available

    September 2017
  52. AZUMA K, Umezu T, Imanishi S, Asano M, et al
    Genetic variations of bone marrow mesenchymal stromal cells derived from acute leukemia and myelodysplastic syndrome by targeted deep sequencing.
    Leuk Res. 2017;62:23-28.
    PubMed     Abstract available

  53. OU R, Huang J, Shen H, Liu Z, et al
    Transcriptome analysis of CD34+ cells from myelodysplastic syndrome patients.
    Leuk Res. 2017;62:40-50.
    PubMed     Abstract available

    July 2017
  54. AGGOUNE D, Sorel N, Bonnet ML, Goujon JM, et al
    Bone marrow mesenchymal stromal cell (MSC) gene profiling in chronic myeloid leukemia (CML) patients at diagnosis and in deep molecular response induced by tyrosine kinase inhibitors (TKIs).
    Leuk Res. 2017;60:94-102.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.